Recent studies have analyzed the potential prognostic role of BRCA1 in early-stage NSCLC, suggesting that BRCA1 is a predictor of survival in only stage III NSCLC (Hu et al., 2019). This evidence concerns the gene BRCA1 and non-small cell lung carcinoma.